Journal Information
Journal ID (publisher-id): chemical
Title: Journal of the Korean Chemical Society
Translated Title (ko): 대한화학회지
ISSN (print): 1017-2548
ISSN (electronic): 2234-8530
Publisher: Korean Chemical Society대한화학회
The imidazole-fused six-membered heterocycles are fundamental chemical structures in biological systems.1 The major interest in ring systems is due to their resemblance to biologically important purines. The imidazo[1,2-a]pyridine has recently received increased attention due to its use in natural products and pharmaceuticals.2 Specifically, arylated imidazo[1,2-a]pyridines are used as drugs to treat various diseases (Fig. 1).3 Many recent biological studies of imidazo[1,2-a]pyridine derivatives have shown a broad spectrum of activities, such as antibacterial,4 antiviral, 5 antiprotozoal,6 respiratory virus fusion inhibitor,7 and anticancer activities.8 Based on previous biological studies, minor changes in the chemical structure of imidazo[1,2-a]pyridines are responsible for significant changes in biological activities.
Therefore, organic chemists have reported various synthetic strategies for the construction of imidazo[1,2-a]pyridines.9 Although extensive synthetic investigations of imidazo [1,2-a]pyridines have been performed,10 the development of new methods remains desirable for the functionalization of imidazo[1,2-a]pyridines under simple and mild reaction conditions. Recently, microwave-mediated organic reactions have attracted considerable attention from organic chemists because microwave heating can accelerate slow thermal reactions with significant energy savings, high chemical yields, and cleaner reactions.11 Our group explored diversification of heterocyclic moieties, such as indole, azaindole, carbazole, and thiazole under microwave reactions with palladium- or copper-catalyzed cross-coupling reactions.12 These reactions are powerful synthetic tools to establish diverse heterocyclic moieties. To establish a heterocyclic chemical library for biological studies, we require a convenient and rapid synthetic procedure to obtain diverse arylated imidazo[1,2-a]pyridines. In this report, we examined the microwave-assisted palladium-catalyzed Suzuki reaction with various bromoimidazo[1,2-a]pyridines, and substituted arylboronic acids to obtain diversified arylated imidazo[1,2-a]pyridines.
The 2-substituted imidazo[1,2-a]pyridines were prepared by condensation of suitable 2-aminopyridine with appropriate haloacetyl derivatives in ethanol refluxing for 12–24 hours, as described previously.13 Further bromination of 2-substituted imidazo[1,2-a]pyridines with NBS provided the corresponding 3-bromoimidazo[1,2-a]pyridines (Scheme 1).
Initially, the reaction of 3-bromoimidazo[1,2-a]pyridine with phenylboronic acid was selected as a preliminary model to establish standard reaction conditions with microwave heating. The reaction conditions were optimized by varying the palladium species, base, solvent, and temperature. The results are summarized in Table 1.
We investigated the effects of different Pd catalysts, bases, and solvents under various reaction temperatures to examine the reactivity and stability of 3-bromoimidazo[1,2-a] pyridine. The reactions showed reasonable yields of desired product with debrominated starting material under 150–170 ℃ (Entry 1–2), but reactions under 110 ℃ provided lower yields of desired products with large amounts of unreacted starting halides (Entry 4). The reaction was performed at 130 ℃ with various alkaline carbonates and provided good yields of desired products (Entries 4-7). The reaction using Cs2CO3 as a base provided higher yields than the reaction using Na2CO3 or K2CO3. The reaction using different ligand substituted palladium species provided the best yields of desired product with Pd(PPh3)4 (Entries 3 and 7–9). Finally, reactions using different solvents were examined with N,N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), 1,4-dioxane, and N,N-dimethylacetamide (DMA). The reaction using DMF gave higher yields of desired product compared with other selected solvents (Entries 3 and 10–12). The vapor pressure of the reaction mixture in the vial was monitored to maintain 3–5 bar using an online-programmed Biotage microwave reactor at 130 ℃. The results showed that optimal conditions for the Suzuki reaction were 1 mol % Pd (PPh3)4 and 1 equiv. Cs2CO3, in DMF at 130 ℃. The aryl-aryl coupling reactions with several 3-bromoimidazo[1,2-a]pyridine and functional group-substituted phenylboronic acids were performed under established optimal reaction conditions to obtain 3-arylated imidazo[1,2-a]pyridine. The results are summarized in Table 2.
The reaction using 3-bromoimidazo[1,2-a]pyridine (1a) with an electron-donating or -withdrawing substituted phenylboronic acid provided reasonable to good yields of desired product (compound 2a–2i), Based on these results, the electronic effect of phenylboronic acids did not strongly influence product yields. The reactions using 2-phenylimidazo[1,2-a]pyridine with the electron-withdrawing substituted phenylboronic acid did not strongly influence yields of the desired product. Other reactions using 3-bromo-2-trifuloromethylimidazo[1,2-a]pyridine gave about 15% higher yields than the reaction using 3-bromoimidazo[1,2-a]pyridine with the same arylboronic acid (2j, 2k, and 2l). The reaction using 2-substitutent of 3-bromoimidazo[1,2-a]pyridine did not show significant electronic effects with substituted arylboronic acids.
We further investigated the scope of the reaction with different isomeric bromoimidazo[1,2-a]pyridines and various phenyl boronic acids using our established reaction conditions. Reactions using 7-bromoimidazo[1,2-a]pyridine with electron-donating or -withdrawing substituted arylboronic acid also gave moderate to good yields of 7- arylimidazo[1,2-a]pyridine (compound 4a–4j). The reactions also showed that the electronic effect of arylboronic acid did not strongly influence product yields.
The reaction using 5- or 6-bromoimidazo[1,2-a]pyridine also proceeded under mild reaction temperatures with good yields of desired product (4k–4p). The yields of coupling product did not depend on the position of bromoimidazo[1,2-a]pyridine. Bromoimidazo[1,2-a]pyridine showed a significantly decreased reaction time for the thermal reaction (6–24 h) versus the microwave-assisted reaction (40 min). Specifically, the microwave-assisted palladiumcatalyzed carbon-carbon was very useful for establishing a diverse arylated imidazo[1,2-a]pyridine library within 1 hour with low % Pd catalyst.
The microwave assisted palladium-catalyzed Suzuki coupling of 3, 5, 6, and 7- bromoimidazo[1,2-a]pyridine with arylboronic acids provided diversified arylimidazo[1,2-a] pyridine derivatives with a short reaction time. Although the yields of coupling product varied with arylboronic acid and isomeric bromoimidazo[1,2-a]pyridine substituents, the reactions could use various arylboronic acids for diversification. The catalyst system also showed valuable development of green and simple procedures for arylated imidazo[1,2-a]pyridine preparations, for use in biological studies.
3-Bromoimidazo[1,2-a]pyridines (1.0 mmol), Cs2CO3 (1.0 mmol), phenylboronic acid (1.2 mmol), Pd(PPh3)4 (0.01 mmol), and DMF (3 mL) were added to a 5-mL vial. The vial was sealed with a crimp cap and placed in a Biotage initiator microwave cavity. After irradiation at 130 ℃ for 40 minutes and subsequent cooling, the reaction mixture was diluted with saturated aqueous ammonium chloride. Products were isolated by extraction into ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated. Products were purified by silica gel column chromatography using a hexane: ethyl acetate: methyl alcohol (4:4:1) eulent. 3-Phenylimidazo [1,2-a]pyridine (2a) was obtained with 69% yields.
1H NMR (CDCl3, 300 MHz): δ 8.33 (d, 1H, J = 3.0Hz, ArH), 7.70 (s, 1H, ArH), 7.67(d, 1H, J = 3.0 Hz, ArH), 7.39−7.56 (m, 5H, ArH), 7.18 (t, 1H, J = 6.0 Hz, ArH), 6.79 (t, 1H, J = 6.0 Hz, ArH). 13CNMR (CDCl3, 75 MHz) : δ 132.6, 132.2, 132.0, 129.3, 129.3, 128.6, 128.4, 128.2, 128.0, 124.2, 123.4, 118.3, 112.6.
[(a)] A. R. Katritziky C. W. Rees Comprehensive Heterocyclic Chemistry IPergamon PressUK19845607and references therein [(b)] J. A. Joule K. Mills Heterocyclic Chemistry5th ed.WILEYUK2010373 [(c)] F. Couty G. Evano A. R. Katritzky C. A. Ramsden E. F. V. Scriven Comprehensive Heterocyclic Chemistry III3th ed.ElsevierOxford200811409
[(a)] A. Elhakmoui A. Gueiffier J. C. Milhavet Y. Blache J. P. Chapat Bioorg. Med. Chem. Lett.199441937 [CrossRef] [(b)] A. Gueiffier M. Lhassani A. Elhakmoui R. Snoeck G. Andrei O. Chavignion J. C. Teulade A. Kerbal M. Essassi J. C. Debouzy J. P. Witurowo Y. Blache J. Balzarini E. DeClercq J. P. Chapat J. Med. Chem.1996392856 [CrossRef] [(c)] M. Lhassani O. Chavignion J. M. Chezal J.C. Teulade J. P. Chapat R. Snoeck G. Andrei J. Balzarini E. DeClercq A. Gueiffier Eur. J. Med. Chem.199934271 [CrossRef] [(d)] C. Hamdouchi J. de Blas M. del Prado J. Gruber B. A. Heinz L. Vance J. Med. Chem.19994250 [CrossRef] [(e)] K. S. Gudmundsson J. D. Williams J. C. Drach L. Townsend J. Med. Chem.2003461449 [CrossRef]
[(a)] A. Scribber R. Dennis S. Lee G. Ouvry D. Perrey M. Fisher M. Wyvratt P. Liberator A. Gurnett C. Brown J. Mathew D. Thomson D. Schmatz T. Biftu European Journal of Medical Chemistry20084311231123 [(b)] A. Scribber R. Dennis S. J. Hong S. Lee D. McIntyre D. Perrey D. Feng M. Fisher M. Wyvratt P. Leavitt P. Liberator A. Gurnett C. Brown J. Mathew D. Thomson D. Schmatz T. Biftu European Journal of Medical Chemistry2008431334
S. Feng D. Hong B Wang X. Zheng K. Miao L. Wang H. Yun L. Gao S. Zhao H. C. Shen ACS Med. Chem.Lett.20156359 [CrossRef]
[(a)] A. Kamal J. S. Reddy M. J. Ramaiah D. Dastagiri E. V. Bharathi M. V. P. Sasar S. N. C.V. L. Pushpavalli P. Ray M. Pal-Bhadra Med. Chem. Commum.20101355355 [(b)] M. A. Vilchis-Reyes A. Zentella M. A. Martinez-Urbina A. Guzman O. Vargas M. T. R. Apan J. L. V. Gallegos E. Diaz European Journal of Medical Chemistry201045379379 [(c)] M. A. Vilchis-Reyes A. Zentella M. A. Martinez-Urbina A. Guzman O. Vargas M. T. R. Apan J. L. V. Gallegos E. Diaz European Journal of Medical Chemistry201045379 [CrossRef] [(d)] Y. B. Kim C. W. Kang S. Ranatunga H. Yang S. M. Sebti J. R. Del Valle Bioorg. Med. Chem. Lett.2014244650 [CrossRef]
[(a)] H. Cao X. Liu J. Liao J. Huang H. Qiu Q. Chen Y. Chen J. Org. Chem.20147911209 [CrossRef] [(b)] J. Yu Y. Jin H. Zhang X. Yang H. Fu Chem. Eur. J.20131916804 [CrossRef] [(c)] S. Wang W. Liu J. Cen J. Huang H. Zhan Tetrahedron Lett.2014551589 [CrossRef] [(d)] N. Masurier R. Aruta V. Gaumet S. Denoyelle E. Moreau V. Lisowski J. Martinez L. T. Maillard J. Org. Chem.2012773679 [CrossRef] [(e)] Y. Tachikawa Y. Nagasawa S. Furuhashi L. Cui E. Yamaguchi N. Tada T. Miura A. Itoh RSV Adv.201555951 [CrossRef] [(f)] E. F. Dimauro J. M. Kennedy J. Org. Chem.2007721013 [CrossRef] [(g)] M. D. Crozet C. Castera-Ducros P. Vanelle Tetraheron Lett2006477061 [CrossRef] [(h)] J. Koubachi S. E. Kazzoli S. Berteina-Raboin A. Mouaddib G. Guillaumet J. Org. Chem.2007727650 [CrossRef]
[(a)] M. Larhed Microwaves in Organic SynthesisSecond ed.Wiley-VCH, Velog GmbH & Co. KGaAWeinheim2006 [(b)] C. O. Kappe D. Dallinger S. S. Murphree Practical, Microwave Synthesis for Organic ChemistsWiley-VCH, Velog GmbH& Co. KGaAWeinheim2009 [(c)] C. O. Kappe Chem. Soc. Rev.2008371127 [CrossRef] [(d)] M. B. Gawande S. N. Shelke R. Zboril R. S. Verma Acc. Chem.Res.2014471338 [CrossRef]
[(a)] J. K. Kwon J. H. Cho Y. S. Ryu S. H. Oh E. K. Yum Tetrahedron2011674820 [CrossRef] [(b)] S. K. Kim J.-H. Kim Y. C. Park J. W. Kim E. K. Yum Tetrahedron201369 [(c)] J. H. Suh H. S. Kang J. E. Kim E. K. Yum Bull. Korean Chem. Soc.201332067 [(d)] J. K. Kwon J. H. Lee T. S. Kim E. K. Yum Bull. Korean Chem. Soc.2016371927 [CrossRef]
H. Cao H. Zhan Y. Lin X. Lin Z. Du H. Jiang Org Lett.2012141688 [CrossRef]